Paralysis News and Research

RSS
Paralysis is the loss of muscle function in part of your body. It happens when something goes wrong with the way messages pass between your brain and muscles. Paralysis can be complete or partial. It can occur on one or both sides of your body. It can also occur in just one area, or it can be widespread. Paralysis of the lower half of your body, including both legs, is called paraplegia. Paralysis of the arms and legs is quadriplegia.
Vagus nerve stimulation prevents hemorrhagic complications following surgery

Vagus nerve stimulation prevents hemorrhagic complications following surgery

VNS technology could help improve lives of people recovering from stroke

VNS technology could help improve lives of people recovering from stroke

XARELTO reduces rates of major bleeding, recurrent blood clots in people with deep vein thrombosis

XARELTO reduces rates of major bleeding, recurrent blood clots in people with deep vein thrombosis

Scientists decipher details of cloaking proteins that protect the toxin that causes botulism

Scientists decipher details of cloaking proteins that protect the toxin that causes botulism

New model of arterial thrombus formation is similar to popular video game

New model of arterial thrombus formation is similar to popular video game

Scientists develop potent compound that promotes wakefulness, remedies sleep disorder narcolepsy

Scientists develop potent compound that promotes wakefulness, remedies sleep disorder narcolepsy

Augmented microscopy may allow neurosurgeons to clearly distinguish cancerous from healthy tissue

Augmented microscopy may allow neurosurgeons to clearly distinguish cancerous from healthy tissue

Findings could lead to new treatment for ALS, dementia

Findings could lead to new treatment for ALS, dementia

SAGE recommends pilot implementation of malaria vaccine to protect young children

SAGE recommends pilot implementation of malaria vaccine to protect young children

CDC publishes reports on infectious and noninfectious diseases

CDC publishes reports on infectious and noninfectious diseases

Asterias’ Phase 1/2a study evaluates dose escalation of AST-OPC1 for cervical spinal cord injury

Asterias’ Phase 1/2a study evaluates dose escalation of AST-OPC1 for cervical spinal cord injury

Genetic mutation linked to ALS, FTD prevents proteins from entering and exiting the cell's nucleus

Genetic mutation linked to ALS, FTD prevents proteins from entering and exiting the cell's nucleus

Synapse Biomedical, IFR to commercialize implantable systems that restore muscle function in paralyzed patients

Synapse Biomedical, IFR to commercialize implantable systems that restore muscle function in paralyzed patients

New breakthrough may provide key to understanding how to treat Muscular Dystrophy

New breakthrough may provide key to understanding how to treat Muscular Dystrophy

RE.WORK showcases future technology and innovations in deep learning software

RE.WORK showcases future technology and innovations in deep learning software

Study discovers direct link between infants' oral-motor movements and auditory speech perception

Study discovers direct link between infants' oral-motor movements and auditory speech perception

Pioneering surgical technique restores hand and arm movement to quadriplegic patients

Pioneering surgical technique restores hand and arm movement to quadriplegic patients

U of T study provides hope for treating ALS and FTD

U of T study provides hope for treating ALS and FTD

Experimental drug shows promise in mice with multiple sclerosis

Experimental drug shows promise in mice with multiple sclerosis

Polio no more in Nigeria, WHO says

Polio no more in Nigeria, WHO says

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.